News & Stories
Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
Family history remains on the National Cancer Institute’s list of risk factors for breast cancer, but what does it mean when cancer “runs in the family?"
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.
This Press Ganey award recognizes institutions who have maintained consistently high levels of excellence in patient experience over a three-year period.
Five Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer.